Functional Brands Receives Nasdaq Delisting Notice for Minimum Bid Price Deficiency
MEHA sits 22% above its 52-week low of $0.18.
Summary
Functional Brands Inc. received a Nasdaq deficiency letter for failing to maintain the minimum $1.00 bid price, initiating a 180-day period to regain compliance and avoid potential delisting.
Key Events · Legal and Risk Events · MEHA
-
Nasdaq Delisting Notice Received
Functional Brands Inc. was notified by Nasdaq that its common stock failed to meet the minimum $1.00 bid price requirement for continued listing.
-
180-Day Compliance Period
The company has until June 29, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
-
Potential Reverse Stock Split
Functional Brands Inc. stated it may consider a reverse stock split as an option to regain compliance, though there is no assurance of success.
Analysis · MEHA · Life Sciences
Functional Brands Inc. has received a notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement for continued listing. The company's stock has traded below this threshold for 30 consecutive business days, putting its Nasdaq listing at significant risk. While there is a 180-day compliance period, the current stock price of $0.2198 indicates a substantial challenge to regain compliance. Potential delisting could severely impact the company's liquidity, investor confidence, and ability to raise capital, making this a critical concern for investors. The company may consider a reverse stock split as an option to regain compliance, but there is no assurance of success.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEHA was trading at $0.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.18 to $8.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.